Business Context and Reporting Period
On April 14, 2025, Ares Acquisition Corporation II (AACT) entered into a Business Combination Agreement with Kodiak Robotics Inc. (Kodiak). Upon closing, AACT will domesticate as a Delaware corporation and change its name to "Kodiak AI, Inc." The transaction is expected to close in the second half of 2025, subject to shareholder approvals and customary closing conditions.
Key Financial Metrics and Transaction Terms
- Aggregate Consideration: Kodiak stockholders will receive shares of New Kodiak Common Stock valued at $2.5 billion (subject to adjustments based on the Redemption Price).
- Pipe Investment: AACT secured $60 million in PIPE investments. The base purchase price equals the Redemption Price, with a 90% discount for investors subscribing $50 million or more.
- Bridge Financing: Kodiak secured $28.3 million in bridge financing via a Second Lien Facility (convertible loan), including $20 million from a Sponsor affiliate. Additionally, $23.6 million in prior interim financing (SAFE Facility) was converted into this loan.
- Earn-Out Structure: Up to 75 million shares of New Kodiak Common Stock and RSUs are available to Kodiak securityholders based on stock price milestones over a four-year period:
- 25 million shares if the VWAP exceeds $18.00 for 20 of 30 consecutive trading days.
- 25 million shares if the VWAP exceeds $23.00 for 20 of 30 consecutive trading days.
- 25 million shares if the VWAP exceeds $28.00 for 20 of 30 consecutive trading days.
- Liquidity and Cash: Available Closing Cash will consist of the AACT trust account balance (less redemptions and transaction expenses), PIPE proceeds, and other cash equivalents. Specific trust account balances and redemption amounts are not provided in this filing.
Material Changes and Governance
The filing details a material change in corporate structure and ownership. AACT will transition from a Cayman Islands exempted company to a Delaware corporation. The post-closing board of directors will consist of seven members in a staggered three-class structure: six directors chosen by Kodiak and one director chosen by the Sponsor (Ares Acquisition Holdings II LP).
Lock-up restrictions will apply for one year following the closing to shares issued as consideration, to the Sponsor, and to directors/officers. These restrictions will lapse early if the stock trades above $12.00 for 20 of 30 consecutive trading days commencing 150 days after closing.
Outlook, Risks, and Contingencies
Conditions to Closing: The transaction is contingent upon AACT shareholder approval, Kodiak stockholder consent, expiration of HSR Act waiting periods, effectiveness of the Registration Statement (Form S-4), and listing approval on the applicable stock exchange.
Risks and Contingencies:
- Redemptions: The amount of cash available at closing is subject to shareholder redemptions, which could reduce the capital available to the combined company.
- Regulatory Approval: Failure to obtain timely regulatory approvals or the imposition of burdensome conditions could delay or terminate the deal.
- Operational Risks: Risks include supply shortages, reliance on third-party manufacturers, delays in the operational roadmap, and the competitive landscape for autonomous trucking technology.
- Termination Rights: The agreement may be terminated if the closing does not occur by January 26, 2026, or if shareholder approvals are not obtained.
Management Commentary: The filing includes forward-looking statements regarding market potential and operational roadmaps but explicitly disclaims any obligation to update these statements. No specific revenue or profit guidance for the combined entity is provided in this text.
Investor Verification Checklist
- Verify the final Redemption Price and the actual number of shares issued to Kodiak stockholders once the trust account balance and redemption requests are finalized.
- Confirm the total cash available at closing after accounting for redemptions and transaction expenses.
- Review the definitive Proxy Statement/Prospectus (Form S-4) for detailed risk factors and the full capitalization table of the combined company.
- Monitor the status of regulatory approvals, specifically under the Hart-Scott-Rodino Act.
- Assess the impact of the $28.3 million convertible bridge loan on future dilution and debt obligations.